ORIGINAL COMPANY-CONTEXT PRACTICE
Build an auditable clinical-study observation table
Original practice scenario: A hypothetical pharmaceutical research dataset includes participants, visits, lab results and corrected submissions. Explain a query design for one analysis-ready result per participant and scheduled visit.
Written for independent practice using company context; this is not a verified question from a company interview.
A REASONED APPROACH
Model answer.
Define observation identity and correction precedence explicitly, preserving source history. The technical task is reliable data assembly; clinical interpretation and eligibility decisions belong to an authorized study specification.
Work through it
- Distinguish participant, scheduled visit, specimen and assay identities; multiple specimens or repeat assays must not be mistaken for duplicate participant visits.
- Select the valid submission version using approved status and sequence rules, then map actual collection times to scheduled windows without inventing missing visits.
- Join independently prepared observation tables at the required grain and report missing, out-of-window and conflicting results as reviewable exceptions.
Tradeoffs to discuss
- A wide analysis table is convenient but can obscure repeated measures; a normalized event history preserves detail while requiring explicit selection logic.
Common pitfalls
- Do not use an arbitrary MAX result to resolve conflicting laboratory submissions.
- Keep deidentified participant keys and avoid exposing personal details in query diagnostics.